TrialThe lancet. HIV2026

Safety, acceptability, and adherence to dapivirine vaginal ring and oral pre-exposure prophylaxis for HIV prevention in the second trimester of pregnancy: a multicountry, open-label, phase 3b randomised trial.

Felix G Mhlanga et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.